Rebecca Lloyd
About Rebecca Lloyd
Rebecca Lloyd is a scientist with a strong background in biochemistry, holding both BA and MA degrees from the University of Cambridge, as well as a PhD. She has worked at several prominent organizations, including AstraZeneca, Adaptimmune, and Cancer Research UK, and has accumulated diverse research experience since 2009.
Work at Adaptimmune
Rebecca Lloyd has been employed as a Scientist at Adaptimmune since 2021. In this role, she contributes to the company's focus on developing T-cell therapies for cancer treatment. Her work involves applying her expertise in biochemistry and research methodologies to advance the company's scientific objectives.
Education and Expertise
Rebecca Lloyd studied at the University of Cambridge, where she earned a BA and MA Cantab in Natural Sciences with a specialization in Biochemistry from 2012 to 2015. She furthered her education at the same institution, completing her Doctor of Philosophy (PhD) in Biochemistry from 2017 to 2021. Additionally, she completed a short course in Human Genetics and Health Issues at The Open University in 2011.
Background
Rebecca Lloyd's early education includes achieving A levels in Biology, Chemistry, French, and Maths at Ulverston Victoria High School from 2010 to 2012. Prior to that, she completed her GCSEs at Dowdales, where she achieved 8A*, 2A, and a distinction from 2005 to 2010. Her academic foundation laid the groundwork for her career in scientific research.
Previous Work Experience
Before her current position at Adaptimmune, Rebecca Lloyd gained diverse experience in the pharmaceutical and research sectors. She worked as an IMED Graduate Scientist at AstraZeneca from 2015 to 2017 and as a Researcher at Polygeia for 10 months in 2015. Additionally, she completed work experience at Roche in 2014 and served as a Summer Research Student at Cancer Research UK for three months in the same year.